Rosetta Genomics Stock Forward View

Rosetta Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Rosetta Genomics' historical fundamentals, such as revenue growth or operating cash flow patterns.

As of 4th of February 2026 the value of rsi of Rosetta Genomics' share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

Sell Peaked

Oversold

Overbought

The successful prediction of Rosetta Genomics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Rosetta Genomics and does not consider all of the tangible or intangible factors available from Rosetta Genomics' fundamental data. We analyze noise-free headlines and recent hype associated with Rosetta Genomics, which may create opportunities for some arbitrage if properly timed.

Using Rosetta Genomics hype-based prediction, you can estimate the value of Rosetta Genomics from the perspective of Rosetta Genomics response to recently generated media hype and the effects of current headlines on its competitors.

Rosetta Genomics after-hype prediction price

USD 0.0

There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Rosetta Genomics Additional Predictive Modules

Most predictive techniques to examine Rosetta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Rosetta using various technical indicators. When you analyze Rosetta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

A naive forecasting model for Rosetta Genomics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Rosetta Genomics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

More About Naive Prediction All Equity Analysis

This model is not at all useful as a medium-long range forecasting tool of Rosetta Genomics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Rosetta Genomics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Rosetta Genomics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rosetta Genomics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Symbol	ROSG
Name	Rosetta Genomics
Type	Stock
Country	United States
Exchange	NASDAQ

Hype Analysis is not found for Rosetta Genomics at this time

We are unable to locate Rosetta Genomics hype analysis at this time. If you believe the equity you are trying to look up is valid, please let us know, and we will check it out.

Hype Analysis

Prediction analysis is currently not available

Other Suggestions

RO	Roche Holding AG	CompanyDelisted
ROG	Rogers	Company
ROBAX	Robinson Tax Advantaged	Mutual Fund
ROE	Astoria Quality Kings	ETF
ROSE	Oasis Labs	Cryptocurrency

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Did you try this?

Run Correlation Analysis Now

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated

All Next

Launch Module

Rosetta Genomics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rosetta Genomics stock to make a market-neutral strategy. Peer analysis of Rosetta Genomics could also be used in its relative valuation, which is a method of valuing Rosetta Genomics by comparing valuation metrics with similar companies.

American Environmental Enzyme Environmental Solutions Worthington Steel Quaker Chemical Merit Medical Systems Kingboard Chemical Holdings Reliance Steel Aluminum American Airlines Group Alcoa Corp Apple Inc Best Buy Co Citigroup SentinelOne CVS Health Corp Chevron Corp

Risk & Return

Correlation

Story Coverage note for Rosetta Genomics

The number of cover stories for Rosetta Genomics depends on current market conditions and Rosetta Genomics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Rosetta Genomics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Rosetta Genomics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Story Categories

Currently Trending Categories

Technical Analysis Fundamental Analysis Hype Perspective Product Development Forecasting Valuation Advice Volatility Leverage Analysis Risk Management Market Trends Investing Education Insider Trading Thematic Ideas Description Latest Stories

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Rosetta Stock

If you are still planning to invest in Rosetta Genomics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rosetta Genomics' history and understand the potential risks before investing.

	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC